I think it's pretty clear that ONT is moving towards commercialization, but it's a question of 'when'. My guess is that their technology won't be broadly available until mid 2013 (but that's just a guess).
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Originally posted by cibertech View PostThat's interesting, Shawn.
How have you estimated that date? Based on something specific?
Ezequiel
Shawn
Comment
-
Originally posted by GW_OK View PostI wonder if the prize is a MinION?
Comment
-
Well the Minion is disposable, so service would not be an issue. The "instrument" per se would be just whatever computer you plugged it into for the run. At least that is what I understand.
I agree the "ION" suffix is just going to be detrimental to any attempt to distinguish themselves from the other sequencers already inhabiting that name space.
That said, ONT seems to have captured a much larger percentage of the "general public" mind-share than Ion Torrent. Reminds me of the situation circa 3 years ago when it was more likely that a member of the public would have heard of "Pacific Biosciences" than "Illumina". Despite the fact the former was pure vaporware at the point whereas Illumina actually had a sequencer to sell. (Or had Solexa been purchased by Illumina at that point?)
--
Phillip
Comment
-
Originally posted by BBoy View PostThey really really really ought to re brand the damn thing. Minion? Really? But I agree that the silence since AGBT has been interesting, as has been the lack of significant hiring activity. Perhaps their instrument is so reliable they need no field service? Or maybe their beta sites are all near headquarter? Both are unlikely.
That aside though, the total lack of any news suggests things aren't on track.
Comment
-
It's a fairly common HR concept to post as many job position as possible. I know company who are constantly sending out employees for a walk of shame with the brown box, the 15 minute clean up and the security guard while posting request on websites for the exact same job... same thing for hiring freezes, a very common practice amongst NGS companies but they would never want you to know.
Comment
-
Two interesting nuggets..
Oxford Nanopore to Unveil New DNA Sequencers This Week
Oxford Nanopore and Illumina in Arbitration Regarding Sequencing Partnership
Comment
-
Interesting indeed.
From the BusinessWeek article:
Code:The MinION will cost less than $1,000, Sanghera said. Its components can be removed, recycled and fitted with new ones at a reduced price
At $1000 a MinION that could add up to some significant dollars.
Originally posted by protist View PostTwo interesting nuggets..
Oxford Nanopore to Unveil New DNA Sequencers This Week
Comment
-
I was thinking it was more like a sub-full price bit that you could swap into the USB stick part. Buy the whole thing for $1k, then pay less than $1k for the little replaceable bit. It makes sense, really, in that you don't have to toss all the computer hardware bits when the minion is used up.
Alternatively, they could give you a trade-in rebate when you swap out old for new, maybe.
Either way, exciting news.
Comment
-
Amazing Post! It has great content that helps in learning and analyzing on things about latest technology in the trend. Thanks for a great post.
Selenium is a portable framework for testing web applications. Selenium provides a playback tool for authoring functional tests without the need to learn a test scripting language (Selenium IDE)
Selenium Training in Velachery
Selenium Training in Tambaram
Comment
Latest Articles
Collapse
-
by seqadmin
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...-
Channel: Articles
09-09-2024, 10:59 AM -
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Today, 06:25 AM
|
0 responses
13 views
0 likes
|
Last Post
by seqadmin
Today, 06:25 AM
|
||
Started by seqadmin, Yesterday, 01:02 PM
|
0 responses
12 views
0 likes
|
Last Post
by seqadmin
Yesterday, 01:02 PM
|
||
Started by seqadmin, 09-18-2024, 06:39 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-18-2024, 06:39 AM
|
||
Started by seqadmin, 09-11-2024, 02:44 PM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-11-2024, 02:44 PM
|
Comment